Drug Development Innovations that Work: Adaptive Trial Designs

In an article printed in BioPharma Dive, Martin Roessner, Vice President, Biostatistics at Parexel discusses adaptive trial designs, their impact on clinical research, the challenges biopharmaceutical companies face implementing them and how to overcome that, recent FDA guidelines and more.

Previous Flipbook
Modifying Methods as seen in International Clinical Trials
Modifying Methods as seen in International Clinical Trials

Next Article
Pilot Study: Using mobile technologies for data capture and transmission
Pilot Study: Using mobile technologies for data capture and transmission